| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 64891 |
DOTA-βA-NH2 |
83 |
h |
2024-12-18 |
| 64892 |
Py-ds-dmBut-OPFP，2101206-44-2，ADC定制 |
66 |
wyh |
2024-12-18 |
| 64893 |
ALD-di-EG-OPFP，ADC定制 |
63 |
wyh |
2024-12-18 |
| 64894 |
cas:2055047-18-0，Azido-PEG3-Val-Cit-PAB-PNP，叠氮-三聚乙二醇-VAL-CIT-PAB-PNP 酯 |
56 |
kx |
2024-12-18 |
| 64895 |
柠檬草精油脂质体,LONL,载药脂质体定制服务 |
83 |
axc |
2024-12-18 |
| 64896 |
cas:159857-79-1，Val-cit-PAB-OH，ADC定制 |
58 |
wyh |
2024-12-18 |
| 64897 |
双载IR780与HCQ的温敏脂质体（IR780/HCQ-Lip） |
102 |
axc |
2024-12-18 |
| 64898 |
endo BCN-PEG3-Val-Cit，(1R,8S,9S)-双环[6.1.0]壬-三聚乙二醇-VAL-CIT |
57 |
kx |
2024-12-18 |
| 64899 |
DOTA-(PEG28)2-A20FMDV2 双末端聚乙二醇化的A20FMDV2偶联DOTA大环配体 |
70 |
h |
2024-12-18 |
| 64900 |
PEG2K-Hyd-PEI聚合物包裹共载SS31肽和胰岛素的脂质体纳米粒,PHP-DPS@INS,NPs |
84 |
axc |
2024-12-18 |
| 64901 |
cas:2226472-28-0 ，DBCO-PEG4-Val-Cit-PAB-PNP，二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-PNP 酯 |
69 |
kx |
2024-12-18 |
| 64902 |
FA-PEG-DOTA 叶酸-聚乙二醇-DOTA |
56 |
h |
2024-12-18 |
| 64903 |
OA-PEG5烷基链定制 |
85 |
zyl |
2024-12-18 |
| 64904 |
共载SS31肽和胰岛素的脂质体纳米粒,DPS@INS,NPs,脂质体纳米载体定制服务 |
87 |
axc |
2024-12-18 |
| 64905 |
DOTA-PEG27-Cys-VS |
61 |
h |
2024-12-18 |
| 64906 |
cas:1613321-01-9 ，6-Azidohexanoyl-Val-Cit-PAB，6-叠氮己酰-VAL-CIT-PAB |
55 |
kx |
2024-12-18 |
| 64907 |
MPA-PEG4-GB-6的功能与应用 |
89 |
zyl |
2024-12-18 |
| 64908 |
DOTA-PEG-GA DOTA-聚乙二醇-甘草次酸 |
59 |
h |
2024-12-18 |
| 64909 |
负载吡非尼酮的肺靶向纳米脂质体,GALA-PFD-Lip,多功能载药脂质体定制服务 |
114 |
axc |
2024-12-18 |
| 64910 |
PAMAM-PG-g-s-s-DOTA(Gd)+FA 纳米球状MRI造影剂 |
68 |
h |
2024-12-18 |
| 64911 |
DBCO-Val-Cit-PAB-MMAE，二苯并环辛炔-VAL-CIT-PAB-MMAE |
51 |
kx |
2024-12-18 |
| 64912 |
脂质体包裹噬菌体ABSZ6（LIP-ABSZ6），载药脂质体定制服务 |
171 |
axc |
2024-12-18 |
| 64913 |
DOTA-3G3-dimer DOTA-3G3-二聚体 |
61 |
h |
2024-12-18 |
| 64914 |
CAS: 1884578-27-1 Alloc-Val-Ala-PAB-PNP |
66 |
WYQ |
2024-12-18 |
| 64915 |
cas:646502-53-6 ，MC-Val-Cit-PAB-MMAE，VCMMAE 单甲基奥瑞他汀E |
78 |
kx |
2024-12-18 |
| 64916 |
布地奈德脂质体,Budesonide,liposomes,BUD-LNPs,靶向脂质体定制服务 |
77 |
axc |
2024-12-18 |
| 64917 |
DOTA-Lys-PEG4-[D-Phe6,Sta13]-BN(6-14)NH2(HZ219)DOTA缀合的GRPr拮抗剂 |
62 |
h |
2024-12-18 |
| 64918 |
[131I]SIB-PEG4-CHC 聚乙二醇化秋水仙素衍生物-定制 |
94 |
zyl |
2024-12-18 |
| 64919 |
PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针 |
55 |
h |
2024-12-18 |
| 64920 |
虾青素脂质体，提供荧光脂质体定制服务 |
81 |
axc |
2024-12-18 |
| 64921 |
PEG2-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2；peg2-RM26-科研定制 |
114 |
zyl |
2024-12-18 |
| 64922 |
DOTA-PEG(4)-[D-Phe(6) |
60 |
h |
2024-12-18 |
| 64923 |
Azide-PEG3-Val-Cit-PAB-MMAF，叠氮-三聚乙二醇-VAL-CIT-PAB-MMAF |
57 |
kx |
2024-12-18 |
| 64924 |
DOTA-3G(3)-dimer DOTA-3G(3)-二聚体 |
79 |
h |
2024-12-18 |
| 64925 |
HS-(CH2)11-triphenylimidazole；HS-(CH2)11-三苯基咪唑 |
82 |
zyl |
2024-12-18 |
| 64926 |
雷公藤甲素脂质体,1-Lips,脂质体纳米载体定制服务 |
72 |
axc |
2024-12-18 |
| 64927 |
DOTAGA-PEG(2)-RM26 DOTA修饰铃蟾肽衍生的GRPR拮抗剂PEG(2)-RM26 |
81 |
h |
2024-12-18 |
| 64928 |
cas:159857-79-1，Val-Cit-PAB，ADC定制 |
52 |
wyh |
2024-12-18 |
| 64929 |
2529982-76-9，Azido-PEG4-Val-Ala-PAB，叠氮-四聚乙二醇-VAL-ALA-PAB |
68 |
kx |
2024-12-18 |
| 64930 |
DOTA-PEG11-Tz DOTA-PEG11-四嗪 |
84 |
h |
2024-12-18 |
| 64931 |
阿霉素-卡铂脂质体,doxorubicin-carboplatin,liposome,DOX/CBP-Lip,多功能载药脂质体定制服务 |
66 |
axc |
2024-12-18 |
| 64932 |
HS(CH2)11OH烷基链定制 |
68 |
zyl |
2024-12-18 |
| 64933 |
NH(2)-PEG-DOTA-PEG-NH(2)-GQDs NH2-PEG-DOTA-PEG-NH2偶联羧基化石墨烯量子点 |
81 |
h |
2024-12-18 |
| 64934 |
Fmoc-Val-Cit-PAB-PNP（CAS:863971-53-3） |
56 |
WYQ |
2024-12-18 |
| 64935 |
Au23(S-c-C6H11)16 烷基链定制 |
64 |
zyl |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询